Real-time enrollment status for this runx1 familial platelet disorder clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 11:50 PM UTC
| NCT Number | NCT06414889 |
| Recruiting Status | Recruiting |
| Condition | RUNX1 Familial Platelet Disorder |
| Phase | PHASE1 |
| Target Enrollment | 4 participants |
| Active Locations | 1 sites in the US |
| Sponsor | M.D. Anderson Cancer Center |
| Last Updated on CT.gov | June 11, 2026 (Jun 11, 2026) |
As of September 1, 2026: Clinical trial NCT06414889 is currently recruiting participants. This phase1 study for runx1 familial platelet disorder is actively seeking new participants at 1 location across the United States. The study is sponsored by M.D. Anderson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06414889 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06414889 was last updated Jun 11, 2026 (June 11, 2026). HelloStudys verifies this status automatically.